{"entity":{"type":"insider","cik":"0001291763","url":"/insider/0001291763","json_url":"/insider/0001291763.json","name":"Phillips Trevor","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":54,"n_filings":8,"first":"2005-09-19","last":"2006-08-10","span_basis":"filed_date"},"name_variants":[{"name":"Phillips Trevor","source":"filing","n_filings":8,"first_seen":"2005-09-19","last_seen":"2006-08-10"}],"transactions":[{"id":3776135,"accession":"0001209191-06-045258","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-06-045258","line_url":"/filing/0001209191-06-045258","is_derivative":false,"issuer_cik":"0001145404","issuer_name":"CRITICAL THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001145404","owner_cik":"0001291763","owner_name":"Phillips Trevor","owner_display_name":"Phillips Trevor","owner_url":"/insider/0001291763","role":"Officer (COO and SVP of Operations)","role_mark":"O","role_mark_label":"Officer (COO and SVP of Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO and SVP of Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10500.0,"shares_display":"10,500","price_per_share":3.994285714285714,"price_display":"3.99","price_state":"stated","total_value":41940.0,"total_display":"41,940.00","total_whole":"41,940","shares_owned_after":5833.0,"shares_owned_after_display":"5,833","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-08-09","filed_date":"2006-08-10","scope":"insider","n_lines":3},{"id":3776124,"accession":"0001209191-06-045258","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-06-045258","line_url":"/filing/0001209191-06-045258","is_derivative":false,"issuer_cik":"0001145404","issuer_name":"CRITICAL THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001145404","owner_cik":"0001291763","owner_name":"Phillips Trevor","owner_display_name":"Phillips Trevor","owner_url":"/insider/0001291763","role":"Officer (COO and SVP of Operations)","role_mark":"O","role_mark_label":"Officer (COO and SVP of Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO and SVP of Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":4.0675,"price_display":"4.07","price_state":"stated","total_value":16270.0,"total_display":"16,270.00","total_whole":"16,270","shares_owned_after":4933.0,"shares_owned_after_display":"4,933","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-08-08","filed_date":"2006-08-10","scope":"insider","n_lines":6},{"id":5206050,"accession":"0001209191-06-015603","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-06-015603","line_url":"/filing/0001209191-06-015603","is_derivative":false,"issuer_cik":"0001145404","issuer_name":"CRITICAL THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001145404","owner_cik":"0001291763","owner_name":"Phillips Trevor","owner_display_name":"Phillips Trevor","owner_url":"/insider/0001291763","role":"Officer (COO and SVP of Operations)","role_mark":"O","role_mark_label":"Officer (COO and SVP of Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO and SVP of Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":6.0004,"price_display":"6.00","price_state":"stated","total_value":15001.0,"total_display":"15,001.00","total_whole":"15,001","shares_owned_after":5933.0,"shares_owned_after_display":"5,933","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-03-06","filed_date":"2006-03-06","scope":"insider","n_lines":2},{"id":5455230,"accession":"0001209191-06-006855","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-06-006855","line_url":"/filing/0001209191-06-006855#line-2","is_derivative":false,"issuer_cik":"0001145404","issuer_name":"CRITICAL THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001145404","owner_cik":"0001291763","owner_name":"Phillips Trevor","owner_display_name":"Phillips Trevor","owner_url":"/insider/0001291763","role":"Officer (COO and SVP of Operations)","role_mark":"O","role_mark_label":"Officer (COO and SVP of Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO and SVP of Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":6.42,"price_display":"6.42","price_state":"stated","total_value":16050.0,"total_display":"16,050.00","total_whole":"16,050","shares_owned_after":3333.0,"shares_owned_after_display":"3,333","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-02-01","filed_date":"2006-02-01","scope":"insider"},{"id":4722852,"accession":"0001209191-06-001295","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-06-001295","line_url":"/filing/0001209191-06-001295","is_derivative":false,"issuer_cik":"0001145404","issuer_name":"CRITICAL THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001145404","owner_cik":"0001291763","owner_name":"Phillips Trevor","owner_display_name":"Phillips Trevor","owner_url":"/insider/0001291763","role":"Officer (COO and SVP of Operations)","role_mark":"O","role_mark_label":"Officer (COO and SVP of Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO and SVP of Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1944.0,"shares_display":"1,944","price_per_share":7.124279835390946,"price_display":"7.12","price_state":"stated","total_value":13849.6,"total_display":"13,849.60","total_whole":"13,850","shares_owned_after":4377.0,"shares_owned_after_display":"4,377","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-01-03","filed_date":"2006-01-04","scope":"insider","n_lines":5},{"id":1387845,"accession":"0001209191-05-060916","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001209191-05-060916","line_url":"/filing/0001209191-05-060916","is_derivative":false,"issuer_cik":"0001145404","issuer_name":"CRITICAL THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001145404","owner_cik":"0001291763","owner_name":"Phillips Trevor","owner_display_name":"Phillips Trevor","owner_url":"/insider/0001291763","role":"Officer (COO and SVP of Operations)","role_mark":"O","role_mark_label":"Officer (COO and SVP of Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO and SVP of Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":6.265,"price_display":"6.26","price_state":"stated","total_value":31325.0,"total_display":"31,325.00","total_whole":"31,325","shares_owned_after":1944.0,"shares_owned_after_display":"1,944","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-12-02","filed_date":"2005-12-02","scope":"insider","n_lines":15},{"id":1704038,"accession":"0001209191-05-055070","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-05-055070","line_url":"/filing/0001209191-05-055070","is_derivative":false,"issuer_cik":"0001145404","issuer_name":"CRITICAL THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001145404","owner_cik":"0001291763","owner_name":"Phillips Trevor","owner_display_name":"Phillips Trevor","owner_url":"/insider/0001291763","role":"Officer (COO and SVP of Operations)","role_mark":"O","role_mark_label":"Officer (COO and SVP of Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO and SVP of Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":6.574594,"price_display":"6.57","price_state":"stated","total_value":32872.97,"total_display":"32,872.97","total_whole":"32,873","shares_owned_after":8344.0,"shares_owned_after_display":"8,344","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-11-02","filed_date":"2005-11-02","scope":"insider","n_lines":5},{"id":1469215,"accession":"0001209191-05-050005","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-05-050005","line_url":"/filing/0001209191-05-050005","is_derivative":false,"issuer_cik":"0001145404","issuer_name":"CRITICAL THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001145404","owner_cik":"0001291763","owner_name":"Phillips Trevor","owner_display_name":"Phillips Trevor","owner_url":"/insider/0001291763","role":"Officer (COO and SVP of Operations)","role_mark":"O","role_mark_label":"Officer (COO and SVP of Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO and SVP of Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":9.0516,"price_display":"9.05","price_state":"stated","total_value":45258.0,"total_display":"45,258.00","total_whole":"45,258","shares_owned_after":12044.0,"shares_owned_after_display":"12,044","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-10-03","filed_date":"2005-10-03","scope":"insider","n_lines":8},{"id":1453907,"accession":"0001209191-05-047852","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-05-047852","line_url":"/filing/0001209191-05-047852#line-9","is_derivative":false,"issuer_cik":"0001145404","issuer_name":"CRITICAL THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001145404","owner_cik":"0001291763","owner_name":"Phillips Trevor","owner_display_name":"Phillips Trevor","owner_url":"/insider/0001291763","role":"Officer (COO and SVP of Operations)","role_mark":"O","role_mark_label":"Officer (COO and SVP of Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO and SVP of Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1200.0,"shares_display":"1,200","price_per_share":5.92,"price_display":"5.92","price_state":"stated","total_value":7104.0,"total_display":"7,104.00","total_whole":"7,104","shares_owned_after":17444.0,"shares_owned_after_display":"17,444","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-09-19","filed_date":"2005-09-19","scope":"insider"},{"id":1453906,"accession":"0001209191-05-047852","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-05-047852","line_url":"/filing/0001209191-05-047852#line-8","is_derivative":false,"issuer_cik":"0001145404","issuer_name":"CRITICAL THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001145404","owner_cik":"0001291763","owner_name":"Phillips Trevor","owner_display_name":"Phillips Trevor","owner_url":"/insider/0001291763","role":"Officer (COO and SVP of Operations)","role_mark":"O","role_mark_label":"Officer (COO and SVP of Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO and SVP of Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1100.0,"shares_display":"1,100","price_per_share":5.91,"price_display":"5.91","price_state":"stated","total_value":6501.0,"total_display":"6,501.00","total_whole":"6,501","shares_owned_after":18644.0,"shares_owned_after_display":"18,644","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-09-19","filed_date":"2005-09-19","scope":"insider"},{"id":1453905,"accession":"0001209191-05-047852","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-05-047852","line_url":"/filing/0001209191-05-047852#line-7","is_derivative":false,"issuer_cik":"0001145404","issuer_name":"CRITICAL THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001145404","owner_cik":"0001291763","owner_name":"Phillips Trevor","owner_display_name":"Phillips Trevor","owner_url":"/insider/0001291763","role":"Officer (COO and SVP of Operations)","role_mark":"O","role_mark_label":"Officer (COO and SVP of Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO and SVP of Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":5.9,"price_display":"5.90","price_state":"stated","total_value":3540.0,"total_display":"3,540.00","total_whole":"3,540","shares_owned_after":19744.0,"shares_owned_after_display":"19,744","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-09-19","filed_date":"2005-09-19","scope":"insider"},{"id":1453904,"accession":"0001209191-05-047852","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-05-047852","line_url":"/filing/0001209191-05-047852#line-6","is_derivative":false,"issuer_cik":"0001145404","issuer_name":"CRITICAL THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001145404","owner_cik":"0001291763","owner_name":"Phillips Trevor","owner_display_name":"Phillips Trevor","owner_url":"/insider/0001291763","role":"Officer (COO and SVP of Operations)","role_mark":"O","role_mark_label":"Officer (COO and SVP of Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO and SVP of Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":5.89,"price_display":"5.89","price_state":"stated","total_value":2945.0,"total_display":"2,945.00","total_whole":"2,945","shares_owned_after":20344.0,"shares_owned_after_display":"20,344","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-09-19","filed_date":"2005-09-19","scope":"insider"},{"id":1453903,"accession":"0001209191-05-047852","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-05-047852","line_url":"/filing/0001209191-05-047852#line-5","is_derivative":false,"issuer_cik":"0001145404","issuer_name":"CRITICAL THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001145404","owner_cik":"0001291763","owner_name":"Phillips Trevor","owner_display_name":"Phillips Trevor","owner_url":"/insider/0001291763","role":"Officer (COO and SVP of Operations)","role_mark":"O","role_mark_label":"Officer (COO and SVP of Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO and SVP of Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":5.87,"price_display":"5.87","price_state":"stated","total_value":2935.0,"total_display":"2,935.00","total_whole":"2,935","shares_owned_after":21144.0,"shares_owned_after_display":"21,144","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-09-19","filed_date":"2005-09-19","scope":"insider"}],"collapsed":true,"next_cursor":"2005-09-19|1453903","ledger_fault":false,"count":{"value":54,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":54,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":54},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001145404","name":"CRITICAL THERAPEUTICS INC","url":"/issuer/0001145404","role":"Officer (COO and SVP of Operations)","n_filings":8,"first_seen":"2005-09-19","last_seen":"2006-08-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001291763","retrieved_at":"2026-08-25T16:50:16+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}